SCHEMBL23057764

SCHEMBL23057764

Cc1nc(N)c2c(-c3ccc(N)cc3Cl)cn(C)c2n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAVCR2 Q8TDQ0 2/20 0.37
CYP3A4 P08684 2/20 0.36
EIF2AK3 Q9NZJ5 6/20 0.35
HSD11B2 P80365 1/20 0.34
PLA2G7 Q13093 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
HTT P42858 1/20 0.33
PRKCI P41743 1/20 0.33
DYRK1A Q13627 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
RAB9A P51151 1/20 0.32
RAD52 P43351 1/20 0.32
TSHR P16473 1/20 0.32
MET P08581 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30060898 1.00 HAVCR2 (0.37) HAVCR2CYP3A4EIF2AK3HSD11B2PLA2G7
SCHEMBL23043996 0.86 CRHR1 (0.39) HAVCR2EIF2AK3SMN1; SMN2ADORA2AADORA1
SCHEMBL29684355 0.86 CRHR1 (0.39) HAVCR2EIF2AK3SMN1; SMN2ADORA2AADORA1
SCHEMBL30060936 0.84 DYRK1A (0.39) CYP3A4EIF2AK3DYRK1AMETAXL
SCHEMBL23057767 0.84 DYRK1A (0.39) CYP3A4EIF2AK3DYRK1AMETAXL
SCHEMBL23057814 0.82 DYRK1A (0.41) EIF2AK3HTTDYRK1AKDM4EMAPT
SCHEMBL20351612 0.79 MET (0.41) HAVCR2EIF2AK3SMN1; SMN2ADORA2AADORA1
SCHEMBL30060920 0.76 DYRK1A (0.40) CYP3A4EIF2AK3ADORA2AADORA1DYRK1A
SCHEMBL23057898 0.72 EIF2AK3 (0.51) EIF2AK3METAXL
SCHEMBL23057901 0.72 KIT (0.40) EIF2AK3MAPTALDH1A1METAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021041975-A1 PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS HIBERCELL, INC. (US) 2021-03-04 WO disclosed